Two doses of the Jynneos monkeypox vaccine, which was developed as a smallpox vaccine, generate relatively low antibody levels with poor capacity to neutralize the virus, according to findings published Aug. 31 in the preprint server medRxiv.
Read the full post on Becker's Hospital Review - Healthcare News
